AlphaCentric Advisors’s Keros Therapeutics KROS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,000
Closed -$465K 255
2024
Q3
$465K Buy
+8,000
New +$465K 0.35% 78